The FASEB Journal, Vol 8, 103-106, Copyright © 1994 by The Federation of American Societies for Experimental Biology

RESEARCH COMMUNICATIONS

Glucose induced genes in bovine aortic smooth muscle cells identified by mRNA differential display

Y Nishio, LP Aiello and GL King
Research Division, Joslin Diabetes Center, Boston, MA 02215.

Hyperglycemia is postulated to cause chronic changes in the vasculature of diabetic patients, suggesting structural or genetic alterations. We have characterized the glucose induced alterations of gene expression in cultured bovine aortic smooth muscle cells using the recently developed mRNA differential display method. After five days of incubation with either 5.5 or 22 mM glucose, RNA preparations were isolated from confluent cells and probed with 10 candidate clones identified after screening up to 3000 mRNA species. Among these, three clones (2A, 2C, 3) showed significant changes in expression by Northern blot analysis. Elevated glucose levels decreased the mRNA expression of clones 2A and 3 to 51 +/- 7% (P < .01) and 59 +/- 10% (P < .05) (mean% of control +/- SEM), respectively. Expression of clone 2C was increased in 22 mM glucose condition to 221 +/- 23% (P < .05). Nucleotide sequence analysis showed that clone 3 had 77% homology to the 3'- noncoding region of human elongation factor 2, a member of the GTPase family which is essential for polypeptide synthesis. Clones 2A and 2C do show no homology to known nucleotide sequences. These results indicate that physiologically attainable high glucose conditions can significantly effect gene expression in aortic smooth muscle cells. Furthermore, mRNA differential display can be used in metabolic studies to identify new genes regulated by nutrients such as glucose.

This article has been cited by other articles:

				J. ST-AMAND, K. OKAMURA, K. MATSUMOTO, S. SHIMIZU, and Y. SOGAWA Characterization of control and immobilized skeletal muscle: an overview from genetic engineering FASEB J, March 1, 2001; 15(3): 684 - 692. [Abstract] [Full Text] [PDF]

				W. A. Bonass, P. D. Marsh, R. S. Percival, J. Aduse-Opoku, S. A. Hanley, D. A. Devine, and M. A. Curtis Identification of ragAB as a Temperature-Regulated Operon of Porphyromonas gingivalis W50 Using Differential Display of Randomly Primed RNA Infect. Immun., July 1, 2000; 68(7): 4012 - 4017. [Abstract] [Full Text] [PDF]

				K. Zibara, M.-C. Bourdillon, E. Chignier, C. Covacho, and J. L. McGregor Identification and Cloning of a New Gene (2A3-2), Homologous to Human Translational Elongation Factor, Upregulated in a Proliferating Rat Smooth Muscle Cell Line and in Carotid Hyperplasia Arterioscler. Thromb. Vasc. Biol., July 1, 1999; 19(7): 1650 - 1657. [Abstract] [Full Text] [PDF]

				J.-F. Wang, C. Bown, and L. T. Young Differential Display PCR Reveals Novel Targets for the Mood-Stabilizing Drug Valproate Including the Molecular Chaperone GRP78 Mol. Pharmacol., March 1, 1999; 55(3): 521 - 527. [Abstract] [Full Text]

				D. A. Wigle, K. E. Thompson, S. Yablonsky, S. H. E. Zaidi, C. Coulber, P. L. Jones, and M. Rabinovitch AML1-like Transcription Factor Induces Serine Elastase Activity in Ovine Pulmonary Artery Smooth Muscle Cells Circ. Res., August 10, 1998; 83(3): 252 - 263. [Abstract] [Full Text] [PDF]

				J. Wada and Y. S. Kanwar Characterization of mammalian translocase of inner mitochondrial membrane (Tim44) isolated from diabetic newborn mouse kidney PNAS, January 6, 1998; 95(1): 144 - 149. [Abstract] [Full Text] [PDF]

				X. Wang and G. Z Feuerstein The use of mRNA differential display for discovery of novel therapeutic targets in cardiovascular disease Cardiovasc Res, September 1, 1997; 35(3): 414 - 421. [Abstract] [Full Text] [PDF]